Medical Oncolgoy Clinics (1B and 1C)
Bone Marrow and Stem Cell Transplantation Program
The Bone Marrow and Stem Cell Transplantation Program focuses on bringing new treatments while at the same time providing a personal and caring approach to the patient.
More...
Duke University Breast Cancer Program.
The Breast Cancer Program at Duke University focuses the efforts of over fifty basic scientists,
medical oncologists, breast surgeons, radiotherapists, nurse practitioners, physicians assistants and research
nurses on one essential goal – improving outcomes for patients with or at risk from breast cancer.
More....
Cancer Biology and Therapy
The training program in adult oncology was established at Duke in late 1959 and has now been in operation for 43 years. The successes of modern cancer treatments have resulted from the coordinated efforts of investigators working both to understand the pathogenesis of cancer and to develop new therapies.
More...
Hemostasis & Thrombosis Program
Duke Comprehensive Hemostasis & Thrombosis Center
The Hemostasis & Thrombosis Center at Duke integrates inpatient and outpatient clinical services with clinical, translational, and basic research programs. The Thrombophilia Program is one of eight national pilot programs supported by the Centers for Disease Control and Prevention.
More...
Oncology Clinical Pharmacology
This Fellowship will prepare physicians for careers in pharmaceutical research and development, in academia, in clinical research, or in a governmental agency that deals with drugs or therapeutics. Duke is one of fourteen NCI designated phase I centers of excellence. Glaxo-Smith-Kline (GSK) is one of the world's leading pharmaceutical companies, with a robust program in new cancer drug development.
More...
Sickle Cell Center
The Duke Comprehensive Sickle Cell Center (DCSCC) is the nucleus of a broad program in clinical care, clinical and basic research, and education for sickle cell anemia and the related hemoglobinopathies.
More...
Thoracic Oncology Program
The Duke Lung program combines the expertise of world-class patient treatment teams with exciting advances in research for patients diagnosed with non-small cell lung cancer, small cell lung cancer, or mesothelioma. For many lung cancer patients, the individualized care offered by Duke presents the best chances of survival and a better chance for a higher quality of life during and after treatment.
More...
DHTS Web Services
DUKE UNIVERSITY
SCHOOL OF MEDICINE
DUKEHEALTH.ORG